INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POOR VISUAL ACUITY
Information
- Show
- FrequencyUpdated weekly
- Published10 September 2024 at 13:22 UTC
- Length7 min
- RatingClean